Interestingly, levels of HMB-45 are lower in metastatic melanoma compared to primary lesions, and its specificity is lower for malignant melanoma in sentinel lymph nodes compared to other markers, such as Melan-A [13]. This evidence concerns the gene PMEL and melanoma.